Skip to main content

Table 5 30-day outcomes

From: Long-term results after mitral valve surgery using minimally invasive versus sternotomy approach: a propensity matched comparison of a large single-center series

 

MIC (N = 422)

CS (N = 422)

p value

Unadjusted OR

Adjusted OR*

n/N

%

n/N

%

Death

11/422

2.6

19/422

4.5

0.137

0.568 (0.267–1.208)

0.893 (0.370–2.156)

Cardiovascular death

5/422

1.2

16/422

3.8

0.015

0.304 (0.110–0.838)

0.402 (0.130–1.247)

Non-CV death

6/422

1.4

3/422

0.7

0.505

2.014 (0.500–8.108)

4.839 (0.952–24.595)

Stroke

9/422

2.1

16/422

3.8

0.155

0.553 (0.242–1.266)

0.524 (0.204–1.342)

Acute renal failure

9/422

2.1

50/422

11.9

< 0.001

0.162 (0.079–0.334)

0.221 (0.101–0.482)

Myocardial infarction

3/422

0.7

0

0

0.249

n.a

n.a

Pacemaker implantation

14/422

3.3

47/422

11.2

< 0.001

0.273 (0.148–0.504)

0.307 (0.155–0.608)

Repeat MV surgery

1/422

0.2

3/422

0.7

0.624

0.332 (0.034–3.202)

0.825 (0.059–11.464)

  1. p values and OR that are statistically significant are highlighted in bold
  2. *Adjusted for procedural differences between the two groups: MV repair, MV replacement, Cryoablation, LAA closure, concomitant TVR; CV cardiovascular, MV mitral valve